Search research articles
Contact Us
Filters
Showing results (61-70 of 85) with videos related to
Page
of 9
Sort By:
Scandinavian Journal of Gastroenterology
|
December 21, 2021
Multinational evaluation of clinical decision-making in the treatment and management of mild-to-moderate ulcerative colitis
Axel U Dignass, Kristine Paridaens, Sameer Al Awadhi, et al.
Journal of Crohn'S & Colitis
|
June 12, 2023
Development of the Escalation of Therapy or Intervention (ETI) Calculator for Patients with Ulcerative Colitis Using ePROMs
Lawrence Matini, Thomas P Chapman, Ramona Kantschuster, et al.
Journal of Crohn'S & Colitis
|
July 22, 2022
Patient-reported Outcomes: the ICHOM Standard Set for Inflammatory Bowel Disease in Real-life Practice Helps Quantify Deficits in Current Care
Darren Wong, Lawrence Matini, Andrey Kormilitzin, et al.
Gut
|
July 10, 2019
Tight control for Crohn's disease with adalimumab-based treatment is cost-effective: an economic assessment of the CALM trial
Remo Panaccione, Jean-Frederic Colombel, Simon P L Travis, et al.
Alimentary Pharmacology & Therapeutics
|
January 13, 2021
Randomised clinical trial: exclusive enteral nutrition versus standard of care for acute severe ulcerative colitis
Pabitra Sahu, Saurabh Kedia, Sudheer K Vuyyuru, et al.
Gut
|
January 31, 2012
A basal gradient of Wnt and stem-cell number influences regional tumour distribution in human and mouse intestinal tracts
Simon J Leedham, Pedro Rodenas-Cuadrado, Kimberley Howarth, et al.
The Lancet Regional Health. Southeast Asia
|
December 11, 2023
Inflammatory bowel disease (IBD) in rural and urban India: results from community colonoscopic evaluation of more than 30,000 symptomatic patients
Rupa Banerjee, Partha Pal, Rajendra Patel, et al.
Gut
|
November 19, 2025
Acute upper gastrointestinal bleeding in the UK: 2022 audit update
Gaurav B Nigam, Kathryn Oakland, Sarah Hearnshaw, et al.
Gut
|
September 28, 2022
Early management of acute severe UC in the biologics era: development and international validation of a prognostic clinical index to predict steroid response
Alex Adams, Vipin Gupta, Waled Mohsen, et al.
Nature Communications
|
November 19, 2021
Defactinib inhibits PYK2 phosphorylation of IRF5 and reduces intestinal inflammation
Grigory Ryzhakov, Hannah Almuttaqi, Alastair L Corbin, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 85) with videos related to
Sort By:
Page
of 9
Scandinavian Journal of Gastroenterology
|
December 21, 2021
Multinational evaluation of clinical decision-making in the treatment and management of mild-to-moderate ulcerative colitis
Axel U Dignass, Kristine Paridaens, Sameer Al Awadhi, et al.
Journal of Crohn'S & Colitis
|
June 12, 2023
Development of the Escalation of Therapy or Intervention (ETI) Calculator for Patients with Ulcerative Colitis Using ePROMs
Lawrence Matini, Thomas P Chapman, Ramona Kantschuster, et al.
Journal of Crohn'S & Colitis
|
July 22, 2022
Patient-reported Outcomes: the ICHOM Standard Set for Inflammatory Bowel Disease in Real-life Practice Helps Quantify Deficits in Current Care
Darren Wong, Lawrence Matini, Andrey Kormilitzin, et al.
Gut
|
July 10, 2019
Tight control for Crohn's disease with adalimumab-based treatment is cost-effective: an economic assessment of the CALM trial
Remo Panaccione, Jean-Frederic Colombel, Simon P L Travis, et al.
Alimentary Pharmacology & Therapeutics
|
January 13, 2021
Randomised clinical trial: exclusive enteral nutrition versus standard of care for acute severe ulcerative colitis
Pabitra Sahu, Saurabh Kedia, Sudheer K Vuyyuru, et al.
Gut
|
January 31, 2012
A basal gradient of Wnt and stem-cell number influences regional tumour distribution in human and mouse intestinal tracts
Simon J Leedham, Pedro Rodenas-Cuadrado, Kimberley Howarth, et al.
The Lancet Regional Health. Southeast Asia
|
December 11, 2023
Inflammatory bowel disease (IBD) in rural and urban India: results from community colonoscopic evaluation of more than 30,000 symptomatic patients
Rupa Banerjee, Partha Pal, Rajendra Patel, et al.
Gut
|
November 19, 2025
Acute upper gastrointestinal bleeding in the UK: 2022 audit update
Gaurav B Nigam, Kathryn Oakland, Sarah Hearnshaw, et al.
Gut
|
September 28, 2022
Early management of acute severe UC in the biologics era: development and international validation of a prognostic clinical index to predict steroid response
Alex Adams, Vipin Gupta, Waled Mohsen, et al.
Nature Communications
|
November 19, 2021
Defactinib inhibits PYK2 phosphorylation of IRF5 and reduces intestinal inflammation
Grigory Ryzhakov, Hannah Almuttaqi, Alastair L Corbin, et al.
Page
of 9